» Articles » PMID: 31908396

Hepatitis C Virus Eradication with Directly Acting Antivirals Improves Health-related Quality of Life and Psychological Symptoms

Overview
Specialty Gastroenterology
Date 2020 Jan 8
PMID 31908396
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alterations in health-related quality of life (HRQoL) and neuropsychological disorders were described in the hepatitis C virus (HCV) patients. Although several studies investigated the modifications of HRQoL after HCV eradication, no data exists on the modifications of neuropsychological symptoms.

Aim: To investigate the effect of directly acting antivirals (DAAs) treatment on HRQoL and neuropsychological symptoms.

Methods: Thirty nine patients with HCV infection underwent a neuropsychological assessment, including Zung-Self Depression-Rating-Scale, Spielberg State-Trait Anxiety Inventory Y1-Y2 and the Toronto-Alexithymia Scale-20 items before and after DAAs treatment. HRQoL was detected by Short-Form-36 (SF-36).

Results: All HRQoL domains, but role limitation physical and bodily pain, significantly improved after treatment. Interestingly, after DAAs treatment, all domains of HRQoL returned similar to those of controls. Each neuropsychological test significantly improved after HCV eradication. A significant correlation was observed among each psychological test and the summary components of SF-36. At multiple linear regression analysis including each psychological test as possible covariates, Zung-Self Depression Rating Scale (Zung-SDS) score was independently and significantly related to summary components of the SF-36 in the basal state and the difference between Zung-SDS score before and after treatment was the only variable significantly and independently related to the modification of HRQoL induced by the treatment.

Conclusion: Neuropsychological symptoms strongly influenced HRQoL in HCV patients and there was a significant improvement of neuropsychological tests and HRQoL after DAAs treatment.

Citing Articles

Randomized controlled effect of treadmill walking exercise on liver enzymes, psychological burden, and erectile dysfunction in men with hepatitis C.

Ismail A, Gressy N, Hegazy M, Abdel-Halim Elfahl A, Ahmed O Prz Gastroenterol. 2025; 19(3):263-270.

PMID: 39802968 PMC: 11718503. DOI: 10.5114/pg.2023.130334.


The Prevalence of Depression and Its Potential Link to Liver Fibrosis in Patients Diagnosed With Chronic Hepatitis C Virus Infection Prior to the Initiation of Direct-Acting Antiviral Treatment.

Stoenescu A, Popescu C, Florescu S, Vancea G, Ceausu E, Calistru P Cureus. 2024; 16(6):e62970.

PMID: 38912074 PMC: 11194022. DOI: 10.7759/cureus.62970.


Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).

Carrieri P, Bourliere M, Di Beo V, Lusivika-Nzinga C, Ramier C, Antwerpes S Qual Life Res. 2023; 32(12):3427-3438.

PMID: 37587323 DOI: 10.1007/s11136-023-03496-w.


From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for Albuminuria.

Hsiao P, Hsiao C, Tsai F, Hou Y, Chiu C, Chiang W Bioengineering (Basel). 2022; 9(10).

PMID: 36290476 PMC: 9598589. DOI: 10.3390/bioengineering9100509.


Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

Ibrahim Salama I, Raslan H, Abdel-Latif G, Salama S, Sami S, Shaaban F World J Hepatol. 2022; 14(6):1053-1073.

PMID: 35978668 PMC: 9258264. DOI: 10.4254/wjh.v14.i6.1053.


References
1.
Marwaha S, He Z, Broome M, Singh S, Scott J, Eyden J . How is affective instability defined and measured? A systematic review. Psychol Med. 2013; 44(9):1793-808. DOI: 10.1017/S0033291713002407. View

2.
Apolone G, Mosconi P . The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998; 51(11):1025-36. DOI: 10.1016/s0895-4356(98)00094-8. View

3.
Bedossa P, Poynard T . An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996; 24(2):289-93. DOI: 10.1002/hep.510240201. View

4.
Garcia-Guerrero M, Sanchez Gomez P, Pena Lasa J, Portu Zapirain J, Elizagarate Zabala E, Gorria Bernal V . Effect of psychiatric symptoms and quality of life on cognitive performance in HCV patients. Rev Psiquiatr Salud Ment (Engl Ed). 2018; 13(1):22-30. DOI: 10.1016/j.rpsm.2018.06.003. View

5.
Ioannou G, Feld J . What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?. Gastroenterology. 2018; 156(2):446-460.e2. DOI: 10.1053/j.gastro.2018.10.033. View